Variant report
Variant | esv3519671 |
---|---|
Chromosome Location | chr2:73430932-73431259 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:73420895..73422888-chr2:73429762..73432345,2 | MCF-7 | breast: | |
2 | chr2:73421814..73423678-chr2:73429913..73432864,2 | K562 | blood: | |
3 | chr2:73429115..73431039-chr2:73464836..73467648,3 | MCF-7 | breast: | |
4 | chr2:73427265..73431524-chr2:73439833..73442659,3 | K562 | blood: | |
5 | chr2:73429491..73432033-chr2:73440311..73443451,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000135632 | chromatin interactions |
ENSG00000135624 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs370390557 | chr2:73430946-73430947 | Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs141519206 | chr2:73430947-73430948 | Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs145946182 | chr2:73430949-73430950 | Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs142613489 | chr2:73430950-73430951 | Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs10199629 | chr2:73430956-73430957 | Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs10164870 | chr2:73430963-73430964 | Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs141530742 | chr2:73430965-73430966 | Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs10199705 | chr2:73430969-73430970 | Bivalent/Poised TSS Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs577120377 | chr2:73431054-73431055 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs541283892 | chr2:73431056-73431057 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs180826122 | chr2:73431060-73431061 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs574462111 | chr2:73431065-73431066 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs187615859 | chr2:73431070-73431071 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs556087981 | chr2:73431072-73431073 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs563667783 | chr2:73431082-73431083 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs531027519 | chr2:73431083-73431084 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs543302641 | chr2:73431088-73431089 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs565026764 | chr2:73431095-73431096 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs532459180 | chr2:73431099-73431100 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs547681078 | chr2:73431102-73431103 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs565702101 | chr2:73431144-73431145 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs113663808 | chr2:73431182-73431183 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs34098755 | chr2:73431196-73431197 | Bivalent Enhancer Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs371759861 | chr2:73431248-73431249 | Bivalent Enhancer Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Developmental delay | 21147756 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:73429400-73431000 | Bivalent/Poised TSS | H9 Cell Line | embryonic stem cell |
2 | chr2:73429800-73431800 | Bivalent Enhancer | Placenta | Placenta |
3 | chr2:73430800-73431400 | Enhancers | HepG2 | liver |
4 | chr2:73431200-73431800 | Weak transcription | Spleen | Spleen |